Mobirix Corrects Stock Option Grant: Massive Reduction from 330,000 to 20,000 Shares, Mitigating Dilution Risk for Existing Shareholders

The CEO changed from Lee Nam-il and Lee Seung-kyun to Im Joong-soo, and the headquarters relocated from Gasan-dong to Seongsu-dong; the stock option grant details were corrected.
Originally, 330,000 shares were granted to two persons (CEO Lee Seung-kyun 310,000 shares, employee Jeong Ji-hwan 20,000 shares), but after correction, only 20,000 shares are granted to employee Jeong Ji-hwan.
The total outstanding options after this grant decreased from 720,000 to 80,000 shares, reducing potential dilution from 3.4% to 0.2% relative to market cap (approx. 23.2B KRW).
The exercise price is 2,532 KRW, slightly above the current price of 2,415 KRW, with an exercise period from March 27, 2028 to March 27, 2033.
The correction was due to the resignation of former CEO Lee Seung-kyun, indicating management changes and possible internal control shifts.
[AI Summary]This corrective filing significantly reduces the stock option grant from 330,000 to 20,000 shares, alleviating dilution risk for existing shareholders. However, the reason for the initial over-granting and the timing of the correction warrants scrutiny. The change in leadership and address also signals a transitional phase for the company.